Related Experiment Video
Updated: Jul 31, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
N Bucay1, I Sarosi, C R Dunstan
1Department of Molecular Genetics, Amgen, Inc., Thousand Oaks, California 91320-1789, USA.
Abstract:
Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG-/- mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly, OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.
Insights
Osteoprotegerin (OPG) is vital for maintaining bone density and preventing fractures. OPG deficiency in mice led to bone loss and unexpected vascular calcification, linking bone health and cardiovascular disease.
Area of Science:
- Biochemistry
- Physiology
- Genetics
Background:
- Osteoprotegerin (OPG) is a key secreted protein that regulates osteoclast formation.
- Osteoclast activity is critical for bone remodeling and maintaining bone mass.
Purpose of the Study:
- To investigate the physiological role of OPG in postnatal bone metabolism.
- To determine the effects of OPG deficiency on bone density and structure.
- To explore potential links between OPG, bone health, and vascular calcification.
Main Methods:
- Generation of OPG-deficient (OPG-/-) mice.
- Assessment of bone density, structure, and porosity in adolescent and adult OPG-/- mice.
- Histological examination of bone and vascular tissues.
Main Results:
- OPG-/- mice exhibited significantly decreased total bone density.
- Severe trabecular and cortical bone porosity, skull bone thinning, and increased fracture incidence were observed.
- Unexpectedly, OPG-/- mice displayed medial calcification of the aorta and renal arteries.
Conclusions:
- OPG is a critical regulator of postnatal bone mass.
- OPG deficiency leads to severe osteoporosis-like phenotypes.
- The findings suggest a potential role for OPG in the association between osteoporosis and vascular calcification.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

